Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Post-transplant Contrast-enhanced Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

NCT02117115 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02117115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Post-transplant Contrast-enhanced Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2014
Completion date
May 31, 2015
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelogenous, chronic, leukemia, myeloid, acute, multiple myeloma, myelodysplastic syndromes